Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), sold 2,610,928 shares at $4.54 ($12.0M) on 2023-08-15, disclosed to the SEC on 2023-08-17.
Open-market sale of $12.0M ADMA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.54 | 510,469 | $2.3M | 19.4% |
| 2 | $4.54 | 510,469 | $2.3M | 19.4% |
| 3 | $4.61 | 1,589,987 | $7.3M | 61.3% |
| 4 | $4.39 | 3 | $13 | 0.0% |
| Total | $4.58 avg | 2,610,928 | $12.0M | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |